Hannah Brendan

EDGAR CIK 0001929422

Quince Therapeutics, Inc. - QNCX

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Officer
CHIEF BUSINESS OFFICER AND COO
Direct Buys
3
$24,166
38,924 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
08/21/2024
08/21/2024
Buy
30,845 @ $0.63
 $19,337 296,540 (11.61%) Direct
08/20/2024
08/21/2024
Buy
5,924 @ $0.60
 $3,579 265,695 (2.28%) Direct
08/19/2024
08/21/2024
Buy
2,155 @ $0.58
 $1,250 259,771 (0.84%) Direct